StockData
Dolby Laboratories, Inc. logo

Dolby Laboratories, Inc. (DLB) stock

DLBNYSEPatent Owners & LessorsFiscal year ends September 27
Financials through Q3 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 30, 2026Score 18/306% above fair value
$64.59−0.07 (-0.11%)

Close on Nov 12, 2026Market cap $6.05BP/E 27.5Yield 2.04%

Dolby Laboratories ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Dolby Laboratories's ebitda for the twelve months ending Jun 26, 2026 was $331.94M, down 10.0% year over year. For fiscal 2025 it was $352.79M, up 5.7% from the year before. Over ten years it grew 2.3% a year on average. The highest annual figure on record is $473.73M in fiscal 2011.

Annual ebitda

PeriodPeriod endValueChange
FY2025Sep 26, 2025$352.79M+5.7%
FY2024Sep 27, 2024$333.89M+11.9%
FY2023Sep 29, 2023$298.31M+1.1%
FY2022Sep 30, 2022$295.07M-33.0%
FY2021Sep 24, 2021$440.25M+42.2%
FY2020Sep 25, 2020$309.62M-9.5%
FY2019Sep 27, 2019$342.20M+29.2%
FY2018Sep 28, 2018$264.79M-20.1%
FY2017Sep 29, 2017$331.44M+4.6%
FY2016Sep 30, 2016$316.95M+12.2%
FY2015Sep 25, 2015$282.36M-13.7%
FY2014Sep 26, 2014$327.00M+9.5%
FY2013Sep 27, 2013$298.51M-26.5%
FY2012Sep 28, 2012$405.87M-14.3%
FY2011Sep 30, 2011$473.73M+2.0%
FY2010Sep 24, 2010$464.32M+18.3%
FY2009Sep 25, 2009$392.40M+25.9%
FY2008Sep 26, 2008$311.60M–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 26, 2026$56.92M-18.2%
Q2 FY2026CQ1 2026Mar 27, 2026$137.04M+6.0%
Q1 FY2026CQ4 2025Dec 26, 2025$86.31M-15.6%
Q4 FY2025CQ3 2025Sep 26, 2025$51.68M-23.7%
Q3 FY2025CQ2 2025Jun 27, 2025$69.57M+26.3%
Q2 FY2025CQ1 2025Mar 28, 2025$129.30M+1.8%
Q1 FY2025CQ4 2024Dec 27, 2024$102.24M+21.6%
Q4 FY2024CQ3 2024Sep 27, 2024$67.71M+284.0%
Q3 FY2024CQ2 2024Jun 28, 2024$55.09M+49.0%
Q2 FY2024CQ1 2024Mar 29, 2024$126.99M-2.7%
Q1 FY2024CQ4 2023Dec 29, 2023$84.09M-25.7%
Q4 FY2023CQ3 2023Sep 29, 2023$17.64M-61.8%
Q3 FY2023CQ2 2023Jun 30, 2023$36.98M-46.5%
Q2 FY2023CQ1 2023Mar 31, 2023$130.46M+98.5%
Q1 FY2023CQ4 2022Dec 30, 2022$113.24M-0.7%
Q4 FY2022CQ3 2022Sep 30, 2022$46.19M-29.5%
Q3 FY2022CQ2 2022Jul 1, 2022$69.12M-12.9%
Q2 FY2022CQ1 2022Apr 1, 2022$65.71M-39.4%
Q1 FY2022CQ4 2021Dec 31, 2021$114.06M-39.0%
Q4 FY2021CQ3 2021Sep 24, 2021$65.52M+14.9%
Q3 FY2021CQ2 2021Jun 25, 2021$79.39M+37.3%
Q2 FY2021CQ1 2021Mar 26, 2021$108.42M-13.9%
Q1 FY2021CQ4 2020Dec 25, 2020$186.92M+171.6%
Q4 FY2020CQ3 2020Sep 25, 2020$57.05M-22.4%
Q3 FY2020CQ2 2020Jun 26, 2020$57.83M+2.8%
Q2 FY2020CQ1 2020Mar 27, 2020$125.92M+1.8%
Q1 FY2020CQ4 2019Dec 27, 2019$68.83M-22.4%
Q4 FY2019CQ3 2019Sep 27, 2019$73.53M+126.7%
Q3 FY2019CQ2 2019Jun 28, 2019$56.27M+329.3%
Q2 FY2019CQ1 2019Mar 29, 2019$123.70M+17.4%
Q1 FY2019CQ4 2018Dec 28, 2018$88.70M-22.1%
Q4 FY2018CQ3 2018Sep 28, 2018$32.44M-22.1%
Q3 FY2018CQ2 2018Jun 29, 2018$13.11M-88.7%
Q2 FY2018CQ1 2018Mar 30, 2018$105.41M+23.2%
Q1 FY2018CQ4 2017Dec 29, 2017$113.84M+29.5%
Q4 FY2017CQ3 2017Sep 29, 2017$41.62M-17.4%
Q3 FY2017CQ2 2017Jun 30, 2017$116.41M–
Q2 FY2017CQ1 2017Mar 31, 2017$85.53M–
Q1 FY2017CQ4 2016Dec 30, 2016$87.88M–
Q4 FY2016CQ3 2016Sep 30, 2016$50.41M–

More Dolby Laboratories figures

See a number that looks wrong?